• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

iBeat Closes Additional $5.5M to Bring Wearable Heart Monitoring Smartwatch to Market

by Fred Pennic 05/02/2018 Leave a Comment

iBeat Extends Seed Round to $4.5M for Wearable Heart Monitoring Smartwatch

iBeat, makers of the heart monitoring smartwatch wearable that perpetually monitors and detects cardiac arrest, heart attack, and atrial fibrillation has closed another $5.5 million in seed funding, bringing to the total funding round to $10 million. The second tranche of funding includes new investors Kairos, 8VC, City Light Capital, Plug and Play Ventures, ChinaRock Capital Management, as well as angel investors Tony Robbins, Josh Kazam, Shlomo Ben-Haim, Dr. Fred St. Goar, and Dr. Uma Valeti.

iBeat has spent the past two years building and validating its sensor-packed ‘Heart Watch’ – an everyday watch that continually monitors a user’s heart rate, blood flow and oxygen levels. Similar to your average medical alert system for seniors, in the case of a life-threatening emergency, iBeat’s heart monitoring smartwatch will instantly alert the user by asking if he or she is O.K. If they reply ‘no’ or don’t respond within five seconds, the smartwatch alerts their loved ones, and emergency responders in real-time, helping ensure immediate care delivery and potentially saving the user’s life. Additionally, loved ones can receive weekly and monthly updates on a user’s health via the cloud-based platform.

The startup plans to utilize the funding to bring their product to market in July, as well as double the team on Marketing, Engineering, and Operations in San Francisco. The company is currently taking pre-orders for its lifesaving Heart Watch and will begin shipping in early summer.

“Our syndicate of investors is arguably the best in the valley,” said Ryan Howard, founder and CEO of iBeat. “We’re thrilled to see such high-caliber, top-tier funds care about investing in companies that not only provide financial return, but also have an immense positive social impact on the community and in people’s daily lives. These are the funds we care about – ones that enable startups like iBeat to change the world for the better.”

Tagged With: Heart Monitoring Smartwatch, iBeat

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |